Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma
- 1 September 2009
- journal article
- Published by Elsevier in Human Pathology
- Vol. 40 (9) , 1224-1233
- https://doi.org/10.1016/j.humpath.2008.12.022
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapseBritish Journal of Cancer, 2007
- Study of matrix metalloproteinases and their inhibitors in breast cancerBritish Journal of Cancer, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomasVirchows Archiv, 2005
- Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaBreast Cancer Research and Treatment, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Inflammation and cancerNature, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002